Jefferies Sticks to Their Buy Rating for AbbVie


Jefferies analyst Ian Hilliker maintained a Buy rating on AbbVie (NYSE: ABBV) on July 13 and set a price target of $100. The company’s shares closed on Friday at $96.63.

According to TipRanks.com, Hilliker is a 2-star analyst with an average return of 2.4% and a 64.3% success rate. Hilliker covers the Healthcare sector, focusing on stocks such as Johnson & Johnson, Merck & Company, and Eli Lilly & Co.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for AbbVie with a $110.33 average price target.

See today’s analyst top recommended stocks >>

AbbVie’s market cap is currently $153.3B and has a P/E ratio of 24.34. The company has a Price to Book ratio of 43.16.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on ABBV:

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts